Cheyne Capital Management (UK) LLP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 181 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2015$1,889,000
-56.0%
172,306
-49.9%
0.89%
-36.3%
Q2 2015$4,298,000
-33.7%
343,670
-41.7%
1.39%
-11.0%
Q1 2015$6,479,000
+19.9%
589,260
+69.1%
1.56%
+9.9%
Q4 2014$5,402,000
+94.9%
348,419
+51.8%
1.42%
+43.8%
Q3 2014$2,772,000229,5770.99%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders